<DOC>
	<DOC>NCT02285764</DOC>
	<brief_summary>The purpose of this study is to investigate the potential effects of a modified carbohydrate nutritional product for obese pregnant women to reduce maternal glycemia.</brief_summary>
	<brief_title>Nutritional Intervention During Gestation and Offspring Health</brief_title>
	<detailed_description />
	<criteria>Voluntarily signed and dated an ICF, approved by an IEC/IRB and provided applicable privacy authorization prior to any participation in the study. Obese (BMI ≥ 30) as determined by prepregnancy BMI. ≥18 years of age. ≥15+0 but ≤16+6 weeks gestation with a singleton pregnancy. Willing to follow supplementation protocol and follow appropriate nutritional guidance and refrain from consuming other caloric nutritional supplements that are not approved by the study staff, if applicable. Willing to provide body composition measures on infant at birth. Willing to consider additional measures if followup studies are conducted. Adverse maternal and/or fetal medical history which is expected to alter blood glucose regulations. Previously diagnosed diabetes, previous gestational diabetes, systemic lupus erythematodes, antiphospholipid syndrome, known renal disease, treated hypertension, uncontrolled hypothyroidism and/or cancer. Taking medications that can impact blood glucose. Previous bariatric surgery. Lactose intolerant and/or has milk protein allergy or requires a special diet regime. Participating in another clinical trial that would impact participation in this study.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>